rs371328036
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001367624.2(ZNF469):c.5266G>A(p.Ala1756Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000213 in 1,550,392 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001367624.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF469 | NM_001367624.2 | c.5266G>A | p.Ala1756Thr | missense_variant | 3/3 | ENST00000565624.3 | NP_001354553.1 | |
ZNF469 | XM_047434810.1 | c.5266G>A | p.Ala1756Thr | missense_variant | 4/4 | XP_047290766.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF469 | ENST00000565624.3 | c.5266G>A | p.Ala1756Thr | missense_variant | 3/3 | NM_001367624.2 | ENSP00000456500 | A2 | ||
ZNF469 | ENST00000437464.1 | c.5182G>A | p.Ala1728Thr | missense_variant | 2/2 | 5 | ENSP00000402343 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000177 AC: 27AN: 152610Hom.: 0 AF XY: 0.000148 AC XY: 12AN XY: 81156
GnomAD4 exome AF: 0.000223 AC: 312AN: 1398070Hom.: 0 Cov.: 95 AF XY: 0.000207 AC XY: 143AN XY: 689520
GnomAD4 genome AF: 0.000125 AC: 19AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74476
ClinVar
Submissions by phenotype
not provided Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2020 | - - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 25, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1728 of the ZNF469 protein (p.Ala1728Thr). This variant is present in population databases (rs371328036, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with ZNF469-related conditions. ClinVar contains an entry for this variant (Variation ID: 437384). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 01, 2022 | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26582918) - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 05, 2016 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 25, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at